Public comment – American Society for Radiation Oncology (ASTRO)
View the guidelines and practice parameters are available for public comment.
Related Articles
Cancer Causes and Prevention
Covers known cancer risk factors, how certain cancers can be prevented, and ongoing research into causes and prevention.
Maintenance Fruquintinib Plus Capecitabine Is Active, Tolerable in RAS/BRAF Wild-Type mCRC
Fruquintinib plus capecitabine demonstrated preliminary efficacy and safety as maintenance therapy in RAS/BRAF wild-type metastatic colorectal cancer.
VJHemOnc – The video journal of hematological oncology
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve…
ASCO 2025 Preview: Practice-Changing Trials to Watch
As the oncology community prepares for the 2025 American Society of Clinical Oncology Annual Meeting, anticipation is running high over a wave of potential practice-changing…
Podcasts | The Hematologist | American Society of Hematology
Podcasts | The Hematologist | American Society of Hematology Podcasts The Hematologist offers podcasts that enhance the reading experience by presenting key results and additional insights…
Roundtable Roundup: Early CAR T-cell Therapy in Multiple Myeloma
In separate live virtual events, Sarah A. Holstein, MD, PhD, and Shashank Cingam, MD, discuss options for a patient with relapsed/refractory multiple myeloma and the…
5-Year Phase 2 Data Show 0% Recurrence Rate After Surgery Omission in Select Patients With Invasive Breast Cancer
No recurrences, disease-free survival events, or deaths were reported in select patients with breast cancer who had surgery omitted.
ASTCT EBMT Relapse Conference
The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 3,900 physicians, investigators and other health care professionals…
ZUMA-12 Suggests Axi-Cel May Be Curative in First-Line, High-Risk LBCL | Blood Cancers Today
The safety results from this phase 2 trial were also consistent with those observed in other studies.
SGO ConnectEd |
Missed out? Check out the latest round-up of SGO releases, on demand! Check out the latest SGO Taskforce for Board Certification Support content, highlighted below.…
